This video details a pathology case involving a 35-year-old female patient with Neurofibromatosis Type 1 (NF1) presenting with a rapidly growing soft tissue mass. Microscopically, the tumor is a malignant spindle cell neoplasm showing a subtle "herringbone" fascicular pattern and marked nuclear atypia. The crucial finding is the presence of abundant rhabdoid cells (rhabdomyoblasts), confirmed by immunohistochemistry (Desmin and Myogenin positivity), representing heterologous muscle differentiation. This specific variant of Malignant Peripheral Nerve Sheath Tumor (MPNST) is known as Malignant Triton Tumor. The discussion covers the histologic hallmarks, the definition and derivation of the "Triton" name, and key diagnostic points for MPNST, including the paradoxical lack of strong S100 expression and the utility of the H3 K27 me3 marker loss.
Summary of the Pathology Case: Malignant Triton Tumor
0:21 Case History: The patient is a 35-year-old female with Neurofibromatosis 1 (NF1) and a rapidly growing, deep soft tissue mass in the trunk. The NF1 history immediately suggests Malignant Peripheral Nerve Sheath Tumor (MPNST).
0:34 Histology: The tumor displays large, pink (eosinophilic) cells, some appearing epithelioid or rhabdoid, combined with spindly cells arranged in fascicles. The tumor is malignant, featuring atypia and mitosis.
1:09 Architectural Pattern: The spindle cells are somewhat arranged in a "herringbone" pattern, where fascicles intersect at sharp angles, a finding associated with some sarcomas.
2:05 Primary Differential Diagnosis: In the context of NF1 and a malignant spindle cell tumor, the main diagnosis considered is Malignant Peripheral Nerve Sheath Tumor (MPNST), a type of neural sarcoma.
2:32 Heterologous Differentiation: The tumor contains numerous large rhabdoid cells which are confirmed to be rhabdomyoblasts (primitive muscle cells) via staining (Desmin and Myogenin positive). This presence of a non-native cell type is called heterologous differentiation.
4:14 Diagnosis: Malignant Triton Tumor: MPNST that contains heterologous muscle differentiation is specifically termed Malignant Triton Tumor.
4:20 Naming Origin: The tumor is named after the Triton salamander, whose regenerating tail produces both neural and skeletal muscle components simultaneously, reflecting the dual lineage found in the tumor.
5:51 Rhabdomyoblast Morphology: The rhabdomyoblasts are characterized by stringy, swirly pink cytoplasm. Finding cross striations in these cells is often extremely difficult, even in this type of heterologous sarcoma.
6:09 MPNST Diagnostic Criteria: A definitive MPNST diagnosis is most reliable when the sarcoma is seen growing out of a pre-existing nerve or neurofibroma, or in a patient with NF1.
6:25 Key Immunostains: The nuclear marker H3 K27 me3 is often lost in MPNST (especially sporadic cases) and is a helpful diagnostic tool.
7:00 S100 and SOX10 Staining: MPNSTs are usually negative or show only weak, patchy staining for neural markers S100 and SOX10 (except for the epithelioid subtype), which helps differentiate them from metastatic melanoma.
7:36 Takeaway: MPNSTs are aggressive tumors. The presence of the Triton (rhabdomyoblast) component does not typically change the tumor's behavior but results in a unique and often complex morphology.